• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Grants
    • Partners
    • NCSG Bylaws
JOIN NOW
✕
Categories
  • Nonalcoholic Steatohepatitis
Tags
  • Nonalcoholic Steatohepatitis (NASH)
Note: this study is at multiple sites in North Carolina
Study title Viking: A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF VK2809 ADMINISTERED FOR 52 WEEKS IN SUBJECTS WITH BIOPSY PROVEN NASH WITH FIBROSIS
Disease or condition NAFLD/NASH with Fibrosis
Study type Interventional (Clinical Trial)
Intervention/treatment VK2809 or Placebo
Phase 2
Study site 1 Duke University
Study location Durham, NC
Principal investigator Manal Abdelmalek, MD; manal.abdelmalek@duke.edu
Study coordinator Angie Shenouda; angie.shenouda@duke.edu
Phone contact (919) 613-8802
Study site 2 Carolinas Medical Center, Center for Liver Disease and Transplant (Atrium Health)
Study location Charlotte, NC
Principal investigator Andrew deLemos, MD
Study coordinator Marina Sycheva, marina.sycheva@atriumhealth.org
Phone Contact 704-446-4835
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04173065

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN NOW